ZA201200963B - Silver oxide formulations having improved whiteness characteristics - Google Patents

Silver oxide formulations having improved whiteness characteristics

Info

Publication number
ZA201200963B
ZA201200963B ZA2012/00963A ZA201200963A ZA201200963B ZA 201200963 B ZA201200963 B ZA 201200963B ZA 2012/00963 A ZA2012/00963 A ZA 2012/00963A ZA 201200963 A ZA201200963 A ZA 201200963A ZA 201200963 B ZA201200963 B ZA 201200963B
Authority
ZA
South Africa
Prior art keywords
silver oxide
improved whiteness
oxide formulations
whiteness characteristics
formulations
Prior art date
Application number
ZA2012/00963A
Other languages
English (en)
Inventor
Perry Antelman
Original Assignee
Aidance Skincare And Topical Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aidance Skincare And Topical Solutions Llc filed Critical Aidance Skincare And Topical Solutions Llc
Publication of ZA201200963B publication Critical patent/ZA201200963B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2012/00963A 2009-07-21 2012-02-09 Silver oxide formulations having improved whiteness characteristics ZA201200963B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22729709P 2009-07-21 2009-07-21
GB1003870A GB2472126B (en) 2009-07-21 2010-03-09 Topical Formulations Containing Silver (II) Oxide and Zinc Oxide
PCT/IB2010/002024 WO2011010221A1 (en) 2009-07-21 2010-07-21 Silver oxide formulations having improved whiteness characteristics

Publications (1)

Publication Number Publication Date
ZA201200963B true ZA201200963B (en) 2013-05-29

Family

ID=42136680

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/00963A ZA201200963B (en) 2009-07-21 2012-02-09 Silver oxide formulations having improved whiteness characteristics

Country Status (11)

Country Link
US (1) US8647647B2 (enExample)
EP (1) EP2456447B1 (enExample)
JP (1) JP5883785B2 (enExample)
KR (1) KR101807885B1 (enExample)
CN (1) CN102470148B (enExample)
AU (1) AU2010274654B2 (enExample)
CA (1) CA2806198C (enExample)
GB (1) GB2472126B (enExample)
IL (1) IL217660A (enExample)
WO (1) WO2011010221A1 (enExample)
ZA (1) ZA201200963B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2487438B8 (en) * 2011-01-24 2014-08-06 Aidance Skincare & Topical Solutions Llc Stable silver oxide formulations
US10391124B2 (en) 2009-07-21 2019-08-27 Aidance Skincare & Topical Solutions Llc Silver oxide formulations
GB2487700A (en) * 2009-11-06 2012-08-01 Aidance Skincare & Topical Solutions Llc Improved silver oxide formulations
US20130189372A1 (en) * 2010-02-06 2013-07-25 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
CN106211756B (zh) * 2014-01-27 2019-12-27 帮助护肤及局部解决方案公司 局部用抗生素制剂
TWI754608B (zh) * 2015-02-08 2022-02-11 以色列商阿爾賈曼技術有限公司 包含金屬氧化物之協同組合的皮膚再生材料
CN107207771B (zh) 2015-02-08 2019-12-06 阿尔贾曼技术有限公司 包含金属氧化物的协同组合的抗微生物材料
TW201630994A (zh) * 2015-02-08 2016-09-01 阿爾賈曼技術有限公司 使用於安全面罩及個人防護衣物的抗微生物織物材料
US11224227B2 (en) 2015-02-08 2022-01-18 Argaman Technologies Ltd. Antimicrobial material comprising synergistic combinations of metal oxides
CZ308301B6 (cs) * 2018-09-17 2020-04-29 Ĺ KODA AUTO a.s. Soustava pro upevnění prosvětlené masky chladiče
DE102024111212A1 (de) * 2024-04-22 2025-10-23 Boehm Medical Protection GmbH Dermale pharmazeutische Zusammensetzung

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2521713A (en) * 1945-07-23 1950-09-12 Sunshine Mining Company Method for producing a microbicidal composition of matter
US4489223A (en) * 1982-07-28 1984-12-18 Smart Start Corporation Battery jump cable apparatus
DE3587286T2 (de) * 1984-12-28 1993-09-23 Johnson Matthey Plc Antimikrobielle zusammensetzungen.
JPH02268104A (ja) * 1989-04-07 1990-11-01 Kanebo Ltd 抗菌性組成物
EP0427858A4 (en) * 1989-02-28 1993-03-10 Kanebo Ltd. Antibacterial or conductive composition and applications thereof
JPH02265605A (ja) * 1989-04-06 1990-10-30 Tetsuo Nishida 固液分離装置
US5336499A (en) * 1992-01-10 1994-08-09 Antelman Technologies, Ltd. Molecular crystal device for pharmaceuticals
US6258385B1 (en) * 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
JP2003519187A (ja) * 2000-01-06 2003-06-17 マランテック ホールディング リミテッド ライアビリティ カンパニー 癌管理のための電子活性化合物の使用方法
US6645531B1 (en) * 2000-01-06 2003-11-11 Marantech Holding Llc Multivalent electron active compositions and methods of making and using same
US6485755B1 (en) * 2000-01-06 2002-11-26 Marantech Holding Methods of using electron active compounds for managing cancer
US20060105057A1 (en) * 2000-01-06 2006-05-18 Marantech Holding, Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US6669966B1 (en) * 2000-01-06 2003-12-30 Marantech Holding Llc Compositions for facilitating skin growth and methods and articles using same
WO2003003809A2 (en) * 2001-07-05 2003-01-16 Marantech Holding, Llc Methods of using electron active compounds for managing conditions afflicting mammals
EP1635771A2 (en) * 2003-04-18 2006-03-22 MERCK PATENT GmbH Cosmetic formulations comprising antimicrobial pigments
US20060017197A1 (en) * 2004-07-20 2006-01-26 Christensen Donald J Coring of compression-molded phenolic
CN100394986C (zh) * 2004-11-09 2008-06-18 深圳市源兴生物医药科技有限公司 一种含银锌组合物的创伤敷料
CN1778313A (zh) * 2004-11-22 2006-05-31 深圳市清华源兴生物医药科技有限公司 一种防治皮肤浅部真菌感染和妇女生殖道感染的药物
US20060171971A1 (en) * 2005-02-01 2006-08-03 The Procter & Gamble Company Composition for wet wipes containing a non-irritating skin health benefit ingredient and the process for making
KR101439555B1 (ko) * 2005-06-27 2014-09-11 스미쓰 앤드 네퓨 피엘씨 항균 물질
US20080014247A1 (en) * 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
JP2010516719A (ja) 2007-01-23 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗菌性組成物
US8894980B2 (en) * 2007-11-19 2014-11-25 U.S. Cosmetics Corporation Wet cake composition for cosmetic products and methods of use

Also Published As

Publication number Publication date
US20110020468A1 (en) 2011-01-27
JP2012533614A (ja) 2012-12-27
WO2011010221A1 (en) 2011-01-27
IL217660A (en) 2016-02-29
JP5883785B2 (ja) 2016-03-15
AU2010274654B2 (en) 2016-04-28
AU2010274654A1 (en) 2012-02-23
EP2456447B1 (en) 2016-08-24
CA2806198A1 (en) 2011-01-27
KR101807885B1 (ko) 2017-12-11
CA2806198C (en) 2018-02-13
KR20120037017A (ko) 2012-04-18
EP2456447A4 (en) 2013-01-02
GB201003870D0 (en) 2010-04-21
GB2472126A (en) 2011-01-26
CN102470148A (zh) 2012-05-23
GB2472126B (en) 2011-08-03
US8647647B2 (en) 2014-02-11
EP2456447A1 (en) 2012-05-30
CN102470148B (zh) 2015-04-01

Similar Documents

Publication Publication Date Title
ZA201200963B (en) Silver oxide formulations having improved whiteness characteristics
ZA201106050B (en) Dye-polymers formulations
ZA201202126B (en) Nano silver-zinc oxide composition
IL216404A0 (en) Hemoglobin compositions
ZA201201326B (en) Doped transparent conductive oxide
IL269369A (en) The vehicles are improved
GB0919210D0 (en) Formulations
GB0922610D0 (en) Earphone
ZA201104757B (en) Novel microbiocides
GB0904658D0 (en) Novel microbiocides
IL219618A0 (en) Improved silver oxide formulations
IL217390A0 (en) Formulations
GB0914489D0 (en) Improved formulations
GB0920983D0 (en) Enhanced copper antibacterial formulations
GB2487438B (en) Stable silver oxide formulations
GB0917744D0 (en) Formulations
AU329320S (en) Lead
IL200881A0 (en) Ear cleaner
GB0905991D0 (en) Novel envelope
GB0903108D0 (en) Novel microbiocides
GB0900991D0 (en) Novel microbiocides
GB0918285D0 (en) Topical formulations
GB0918286D0 (en) Topical formulations
TWM369933U (en) Porcelain package structure
TWM372600U (en) Earphone structure